#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic inflammatory myopathy Langerhans' cell histiocytosis Laryngeal squamous cell carcinoma Univentricular heart Ewing's sarcoma recurrent Oesophageal achalasia Thrombotic microangiopathy Alternating hemiplegia of childhood Epilepsy with myoclonic-atonic seizures Pulmonary tuberculosis Plasma cell myeloma recurrent Hypereosinophilic syndrome Endocrine ophthalmopathy Cytomegalovirus infection Diffuse large B-cell lymphoma More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Diagnostics Angiosarcoma recurrent – Trials in Disease Atypical haemolytic uraemic syndrome – Trials in Disease Hairy cell leukaemia – Treatment Marfan’s syndrome – Trials in Disease Systemic mastocytosis – Diagnostics Short-bowel syndrome – Life with Disease Hereditary optic atrophy KBG syndrome – Trials in Disease Nephrotic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lerodalcibep Alrefimotide S-241656 Vatiquinone GSKVX000000034794 Crofelemer Rozanolixizumab Plitidepsin Sodium Oxybate Lysine Aspirin Glasdegib Selgantolimod Belatacept Glycine Xp-Dc+Tl+Klh Ltp001 Enzalutamide Soticlestat Pyridoxine Hydrochloride Quinapril Hydrochloride More therapies…

    Learn about Your Condition

    Gastrectomy Laryngeal cancer stage III Eczema Chronic kidney disease Kawasaki's disease Primary adrenal insufficiency End stage renal disease Multiple sclerosis H1N1 influenza Pneumonia Restless legs syndrome Type 2 diabetes mellitus Hypoglycaemia Eye inflammation Hyperkalaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glioblastoma multiforme

  • Study on Gemcitabine for Patients with Recurrent Glioblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    • Glioblastoma multiforme
    Investigated Drugs:
    • Gemcitabine
    Norway

  • Study of autologous mature dendritic cell vaccine plus atezolizumab in patients with recurrent glioblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Atezolizumab
    • Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
    Germany

  • Study on the Effectiveness of Valganciclovir for Patients with Glioblastoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Valganciclovir
    Norway Sweden

  • Study of Berubicin versus Lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Berubicin Hydrochloride
    • Lomustine
    France Italy Spain

  • Study on Early Temozolomide Treatment for Adults with Glioblastoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    • Glioblastoma multiforme
    Investigated Drugs:
    • Temozolomide
    Belgium France
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!